 - Demonstrated progressive disease on or after first-line chemotherapy for stage IIIBIV disease. The first-line therapy must consist of platinum-based regimens in combination with taxanes,gemcitabine or vinorelbine.. Stage IIIBIV patients must have measurable disease tumor without clinically significant pleural unless the pleural effusion can be effectively drained prior to admission into the study. 